Stock Market

Globalstar (NYSEAMERICAN:GSAT) has been on a roller coaster ride so far in 2021. GSAT stock, a satellite communications and internet-of-things (IoT) play, zoomed from 34 cents to just over $2.50 per share during February’s “meme stock” mania. Source: NicoElNino / Shutterstock.com Then, in the spring — as this trend cooled — shares dipped back to around
0 Comments
Joby Aviation (NASDAQ:JOBY) stock is down 31% since emerging from a SPAC deal with Reinvent Technology Partners on Aug. 11. That makes sense, because Joby is a “pre-revenue” company. Investors have nothing to judge JOBY stock by except plans, sponsors and a prototype. Source: T. Schneider / Shutterstock.com The company intends to deliver an electric
0 Comments
Editor’s note: This column is part of InvestorPlace.com’s Best Stocks for 2021 contest. Louis Navellier’s pick for the contest is Fiverr International (NYSE:FVRR) stock. FVRR stock has been struggling of late, but the core reason is somewhat ironic. It’s because the pandemic is fading. Source: by InvestorPlace The U.S. added just 194,000 jobs in September, while the lowest
0 Comments
A very popular term in business is disruption, or causing a radical change through innovation. Hippo Holdings (NYSE:HIPO) is a digital homeowners insurance provider that went public in August. Potential HIPO stock investors wonder if this insurance provider will disrupt the insurance market. Source: TDKvisuals / Shutterstock.com It seems to me that HIPO stock lacks
0 Comments
There are many reasons to believe the share price of QuantumScape (NYSE:QS) stock should rise. After all, the company is developing solid-state lithium EV batteries for future commercialization. Yet, QS stock is down almost 73% year-to-date. What’s with the disconnect? Source: Michael Vi / Shutterstock.com Such batteries promise a quantum leap over current dominant lithium-ion
0 Comments
After rising over $100 briefly this year, Cassava Sciences (NASDAQ:SAVA) stock is struggling to rebound. A long document written by the lawyer of a short-seller sent SAVA stock lower. The document challenged the accuracy of some of Cassava’s clinical results Source: Atthapon Raksthaput / Shutterstock.com Cassava has two major clinical studies underway. The top-line data
0 Comments
After breaking out of major resistance in August, Palantir (NYSE:PLTR) stock is on the way to topping its 52-week high. The Reddit favorite is attracting buyers after a recent deal with Wejo, a global leader in connected vehicle data. Source: Ascannio / Shutterstock.com Palantir’s alliance with Wejo is important, even though the deal will have
0 Comments